Edition:
United States

Horizon Pharma PLC (HZNP.OQ)

HZNP.OQ on NASDAQ Stock Exchange Global Select Market

19.07USD
19 Oct 2018
Change (% chg)

$-0.02 (-0.10%)
Prev Close
$19.09
Open
$19.10
Day's High
$19.57
Day's Low
$19.00
Volume
277,527
Avg. Vol
385,079
52-wk High
$21.25
52-wk Low
$12.58

Chart for

About

Horizon Pharma Public Limited Company is a biopharmaceutical company. The Company is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. As of December 31, 2016, the Company marketed 11 medicines through its orphan, rheumatology and primary... (more)

Overall

Beta: 1.31
Market Cap(Mil.): $2,211.82
Shares Outstanding(Mil.): 163.35
Dividend: --
Yield (%): --

Financials

  HZNP.OQ Industry Sector
P/E (TTM): -- 30.90 33.64
EPS (TTM): -2.69 -- --
ROI: -13.86 14.75 14.27
ROE: -36.88 16.24 15.99

BRIEF-Horizon Pharma Q1 Non-Gaap Earnings Per Share $0.03

* REPORTS STRONG FIRST-QUARTER 2018 ORPHAN AND RHEUMATOLOGY NET SALES GROWTH; INCREASES FULL-YEAR 2018 GUIDANCE AND ANNOUNCES NEW COMPANY OPERATING STRUCTURE TO ENHANCE FOCUS ON RARE DISEASES

May 09 2018

BRIEF-AGC Biologics Enters Commercial Manufacturing Agreement With Horizon Pharma

* AGC BIOLOGICS SAYS ENTERS INTO COMMERCIAL MANUFACTURING AGREEMENT WITH HORIZON PHARMA PLC FOR COMMERCIAL SUPPLY OF TEPROTUMUMAB Source text for Eikon: Further company coverage:

May 03 2018

Earnings vs. Estimates